Atyr Pharma Inc (NASDAQ:ATYR) traded at $3.09 at last check on current trade day and made an upward move of 1.71% on its previous day’s price.
Looking at the stock we see that its previous close was $3.04 and the beta (5Y monthly) reads 1.21 with the day’s price range being $2.88 – $3.15. In terms of its 52-week price range, ATYR has a high of $3.68 and a low of $1.08. The company’s stock has gained about 65.34% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Atyr Pharma Inc has a market cap of $228.34 million and is expected to release its quarterly earnings report on 2024-Nov-07. Estimates by analysts give the company expected earnings per share (EPS) of -0.22, with the EPS growth for the year raised at -0.91 for current year and -0.91 for next year.
According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 250k, or -29.20% down from figures reported last year.
On the other hand, looking at the outlook for the ATYR stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Looking further, we note the current price level is 8.21% off its SMA20 and 38.10% from its 50-day simple moving average. The RSI (14) is pointing at 66.49 while the volatility over the past week is 7.95% and jumps to 9.35% over the past one month. The beta value is 1.06, while the average true range (ATR) is currently pointing at 0.23.
Coming back to Atyr Pharma Inc (NASDAQ:ATYR), we note that the average 3-month trading volume was 726.92K, while that of the preceding 10-day period stands at 1.33 million. Current shares outstanding are 75.80 million.
The insiders hold 2.61% of the company’s shares while institutions hold 70.16%. The data shows that short shares as of 2024-10-15, stood at 1.07 million at a short ratio of 1.15. This represents a 191.00 short interest in shares outstanding on 2024-10-15. Shares short rose in October from the previous month at 0.69 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 119.28% up in year-to-date price movement.
